Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein A-I-containing particles and reverse cholesterol transport in IDDM.

C Fievet1, N Theret, N Shojaee

  • 1Institut Pasteur, INSERM, Lille, France.

Diabetes
|October 1, 1992
PubMed
Summary

Glycosylation of lipoprotein A-I (Lp A-I) in diabetes impairs its cholesterol efflux function. This finding is crucial for understanding atherosclerosis protection in diabetic patients with poorly controlled blood sugar.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical challenges and occurrence of antibiotics in biosolids from municipal sewage treatment plants in North Spain.

Journal of chromatography. A·2026
Same author

Assessment of LC-QTOF-MS data independent acquisition for quantification and suspect screening of pesticides in agriculture impacted water samples.

Journal of chromatography. A·2025
Same author

Chronic trophic disorders in cocaine and heroin injectors: A multicenter retrospective observational descriptive study.

Annales de dermatologie et de venereologie·2024
Same author

Identification of hazardous organic compounds in e-waste plastic using non-target and suspect screening approaches.

Chemosphere·2024
Same author

HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis - data from the ReumaCov-Brasil Registry.

Advances in rheumatology (London, England)·2023
Same author

Laparoscopic repair of an anterior perineal hernia: a video presentation.

Facts, views & vision in ObGyn·2023

Area of Science:

  • Cardiovascular Science
  • Metabolic Disorders
  • Lipid Metabolism

Background:

  • High-density lipoproteins (HDL) containing apolipoprotein A-I (apoA-I) protect against atherosclerosis by facilitating cholesterol efflux and reverse cholesterol transport.
  • Previous research indicates that in vitro nonenzymatic glycosylation of HDL diminishes its capacity for cholesterol efflux via HDL receptors.

Purpose of the Study:

  • To investigate the impact of glycosylation on the cholesterol efflux properties of lipoprotein A-I (Lp A-I) particles isolated from diabetic patients.
  • To compare Lp A-I from diabetic and non-diabetic individuals regarding lipid composition and cholesterol efflux promotion.

Main Methods:

  • Isolation of Lp A-I particles from two poorly controlled insulin-dependent diabetic patients and two matched non-diabetic control subjects.

Related Experiment Videos

  • Analysis of lipid composition and assessment of the ability to promote cholesterol efflux from cultured adipose cells.
  • Separation of Lp A-I from diabetic subjects based on the degree of glycosylation.

    • Main Results:

    • No significant differences in lipid composition or cholesterol efflux capacity were observed between Lp A-I from diabetic and non-diabetic subjects overall.
    • When fractionated by glycosylation, Lp A-I from diabetic subjects showed that glycosylated subfractions were approximately 50% less effective in promoting cholesterol efflux compared to non-glycosylated particles.

    Conclusions:

    • Nonenzymatic glycosylation of Lp A-I in poorly controlled diabetes significantly impairs its function in promoting cellular cholesterol efflux.
    • These findings highlight a specific mechanism by which diabetes may compromise the atheroprotective functions of HDL particles, particularly Lp A-I.